24.06.2024 08:09:38 - dpa-AFX: *GSK'S OMJJARA APPROVED IN JAPAN FOR TREATMENT OF MYELOFIBROSIS

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GSK PLC LS-,3125 A3DMB5 Xetra 17,920 04.07.24 13:28:44 +0,165 +0,93% 17,885 17,915 17,860 17,755

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH